Search research articles

Search research articles

Related Experiment Videos

Fc receptor-like molecules.

Randall S Davis¹

¹Division of Developmental and Clinical Immunology, Department of Medicine, University of Alabama at Birmingham, Birmingham, Alabama 35294-3300, USA. rsdavis@uab.edu

Annual Review of Immunology

|January 5, 2007

Summary

This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

NCCN Guidelines® Insights: Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Version 2.2026.

Journal of the National Comprehensive Cancer Network : JNCCN·2026

Same author

Human anti-glycan reactivity emerges from B cells utilizing private gene rearrangements that are affinity maturated in germinal centers.

Immunity·2026

Same author

Roads and detours for CAR T cell therapy in autoimmune diseases.

Nature reviews. Drug discovery·2026

Same author

Human Anti-Glycan Reactivity is Driven by the Selection of B cells Utilizing Private Antibody Gene Rearrangements that are Affinity Maturated in Germinal Centers.

bioRxiv : the preprint server for biology·2024

Same author

Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Version 2.2024, NCCN Clinical Practice Guidelines in Oncology

Journal of the National Comprehensive Cancer Network : JNCCN·2024

Same author

FCRL1 immunoregulation in B cell development and malignancy.

Frontiers in immunology·2023

Same journal

The Neuroimmune Circuitry of Peripheral Sensory Neuron Subtypes in Chronic Pain.

Annual review of immunology·2026

Same journal

The Spectrum of Fibroblast Immune Biology.

Annual review of immunology·2026

Same journal

The Molecular Logic of Immunoglobulin Heavy Chain Class Switch Recombination.

Annual review of immunology·2026

Same journal

Decoding Human T Cell Immunity with Artificial Intelligence and Single-Cell Genomics.

Annual review of immunology·2026

Same journal

Immune Niches in Cancer.

Annual review of immunology·2026

Same journal

T Cell Receptor Signaling and Immune Tolerance: From Autoimmunity to Cancer Immunity.

Annual review of immunology·2026

See all related articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Fc receptor-like (FCRL) molecules, a large gene family, are homologous to Fc receptors (FCR) and show significant diversity. These molecules play a key role in B cell immunity and may be involved in autoimmune disorders.

Area of Science:

Immunology
Genetics
Molecular Biology

Background:

Discovery of Fc receptor-like (FCRL) molecules, homologous to Fc receptors (FCR).
Identification of a large family of immunoglobulin superfamily (IgSF) genes in the human 1q21-23 region.
Significant genetic diversity observed between human and mouse FCRL genes.

Purpose of the Study:

To investigate the evolutionary relationship between FCRL and classical FCR.
To characterize the structural and functional properties of FCRL molecules.
To explore the potential role of FCRL in B cell biology and disease.

Main Methods:

Comparative genomics to analyze FCRL gene family evolution.
Molecular characterization of FCRL structure and signaling.

Related Experiment Videos

Analysis of FCRL expression in B lineage cells and disease states.

Main Results:

FCRL molecules belong to an ancient multigene family sharing common ancestry with classical FCR.
FCRL exhibit diverse extracellular domains, unique signaling capabilities, and preferential expression in B cells.
No evidence supports FCRL as direct immunoglobulin-binding receptors.
FCRL are implicated in malignancies and autoimmune disorders.

Conclusions:

FCRL molecules represent a distinct class of immunomodulatory receptors.
These receptors play a fundamental role in normal and aberrant B cell function.
FCRL are potential therapeutic targets for B cell-related diseases.